PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology, Tufts Medical Center, Boston, Massachusetts elacson@tuftsmedicalcenter.\', \'Dialysis Clinic, Inc., Nashville, Tennessee.\', \'Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, New Mexico.\', \'Division of Nephrology, University of California, Sacramento, California.\', \'Division of Nephrology, Albany Medical College, Albany, New York.\', \'Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1681/ASN.2021040432
?:doi
?:hasPublicationType
?:journal
  • Journal of the American Society of Nephrology : JASN
is ?:pmid of
?:pmid
?:pmid
  • 34348908
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.819
?:rankingScore_hIndex
  • 246
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all